Stockreport

PAVmed down 18% on extended review timeline for CarpX device [Seeking Alpha]

PAVmed Inc.  (PAVM) 
US:NASDAQ Investor Relations: ir.pavm.com
PDF Nano cap PAVmed ( PAVM ) is down on increased volume in response to its disclosure that it will resubmit its U.S. application seeking clearance for its Carp [Read more]